These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15380811)

  • 1. Oxysteroids: a new class of steroids with autocrine and paracrine functions.
    Javitt NB
    Trends Endocrinol Metab; 2004 Oct; 15(8):393-7. PubMed ID: 15380811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel sterols synthesized via the CYP27A1 metabolic pathway.
    Pikuleva I; Javitt NB
    Arch Biochem Biophys; 2003 Dec; 420(1):35-9. PubMed ID: 14622972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of the sterol 27-hydroxylase gene ( CYP27A1) in a Taiwanese family with cerebrotendinous xanthomatosis.
    Lee MJ; Huang YC; Sweeney MG; Wood NW; Reilly MM; Yip PK
    J Neurol; 2002 Sep; 249(9):1311-2. PubMed ID: 12242561
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.
    Gallus GN; Dotti MT; Federico A
    Neurol Sci; 2006 Jun; 27(2):143-9. PubMed ID: 16816916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxysterols: functional significance in fetal development and the maintenance of normal retinal function.
    Javitt NB
    Curr Opin Lipidol; 2007 Jun; 18(3):283-8. PubMed ID: 17495602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights into the Smith-Lemli-Opitz syndrome.
    Yu H; Patel SB
    Clin Genet; 2005 Nov; 68(5):383-91. PubMed ID: 16207203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic role(s) of the 25(R),26-hydroxycholesterol metabolic pathway.
    Javitt NB
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):136-41. PubMed ID: 11111083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO.
    Björkhem I; Diczfalusy U; Lövgren-Sandblom A; Starck L; Jonsson M; Tallman K; Schirmer H; Ousager LB; Crick PJ; Wang Y; Griffiths WJ; Guengerich FP
    J Lipid Res; 2014 Jun; 55(6):1165-72. PubMed ID: 24771866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis.
    Battaile KP; Steiner RD
    Mol Genet Metab; 2000; 71(1-2):154-62. PubMed ID: 11001806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exon skipping in the sterol 27-hydroxylase gene leads to cerebrotendinous xanthomatosis.
    Verrips A; Steenbergen-Spanjers GC; Luyten JA; Wevers RA; Wokke JH; Gabreëls FJ; Wolthers BG; van den Heuvel LP
    Hum Genet; 1997 Aug; 100(2):284-6. PubMed ID: 9254865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of sterol synthesis: beyond Smith-Lemli-Opitz syndrome.
    Herman GE; Kratz L
    Am J Med Genet C Semin Med Genet; 2012 Nov; 160C(4):301-21. PubMed ID: 23042573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
    Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
    J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
    Siman-Tov T; Meiner V; Gadoth N
    J Neurol Sci; 2006 Apr; 243(1-2):83-6. PubMed ID: 16445943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome.
    Hall P; Michels V; Gavrilov D; Matern D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
    Mol Genet Metab; 2013; 110(1-2):176-8. PubMed ID: 23628460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrotendinous xanthomatosis with predominant parkinsonian syndrome: further confirmation of the clinical heterogeneity.
    Dotti MT; Federico A; Garuti R; Calandra S
    Mov Disord; 2000 Sep; 15(5):1017-9. PubMed ID: 11009219
    [No Abstract]   [Full Text] [Related]  

  • 16. Spinal phenotype of cerebrotendinous xanthomatosis--a pitfall in the diagnosis of multiple sclerosis.
    Bartholdi D; Zumsteg D; Verrips A; Wevers RA; Sistermans E; Hess K; Jung HH
    J Neurol; 2004 Jan; 251(1):105-7. PubMed ID: 14999499
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxysterols: novel biologic roles for the 21st century.
    Javitt NB
    Steroids; 2008 Feb; 73(2):149-57. PubMed ID: 18068744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of nine novel DHCR7 missense mutations in patients with Smith-Lemli-Opitz syndrome (SLOS).
    Waye JS; Krakowiak PA; Wassif CA; Sterner AL; Eng B; Nakamura LM; Nowaczyk MJ; Porter FD
    Hum Mutat; 2005 Jul; 26(1):59. PubMed ID: 15954111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome.
    Correa-Cerro LS; Porter FD
    Mol Genet Metab; 2005 Feb; 84(2):112-26. PubMed ID: 15670717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational spectrum of Smith-Lemli-Opitz syndrome.
    Waterham HR; Hennekam RC
    Am J Med Genet C Semin Med Genet; 2012 Nov; 160C(4):263-84. PubMed ID: 23042628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.